• R Dhôte, A L Basse-Guerineau, C Bachmeyer, B Christoforov, and M V Assous.
• Service de Médicine interne, Hôpital Cochin, Paris. robin.dhote@cch.hop-ap-paris.fr
• Presse Med. 1998 Dec 12; 27 (39): 2043-7.

AbstractCAUSAL AGENTS: Several Borrelia burgdorferi sensu lato species have been recently described which cause different clinical forms of Lyme disease. B. garinii is implicated in neurological forms, B. burgdorferi sensu stricto in articular forms and B. afzelii in late cutaneous forms. As such disease diversity is seen only in Europe and Asia, clinical management in Europe is somewhat different than in North America. NUMEROUS CLINICAL TRIALS: A recently proposed classification of the European forms of Lyme disease is based on clinical presentation: contagious conditions or erythema migrans, early neurologic or cardiologic complications, late articular, neurologic or cutaneous complications. Therapeutic proposals should be guided by the results of European trials, taking into account this classification.

16 keywords...

hide…